Metropolis Healthcare gets nod to acquire Hitech

18 Jan 2021 Evaluate

Metropolis Healthcare has received approval for acquisition of entire 100% stake in Dr. Ganesan’s Hitech Diagnostic Centre and its subsidiary (Hitech) from its existing promoters and shareholders. The consideration will be discharged partly by cash and partly by issuance of equity shares of the company. The board of director of the company in their meeting held on January 17, 2021 has approved the same.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

Metropolis Health. Share Price

2131.90 -42.70 (-1.96%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7236.35
Max Healthcare Inst 1193.20
Narayana Hrudayalay 1280.95
Aster DM Healthcare 494.95
Global Health 1133.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.